Weiter zum Inhalt
Toggle navigation
English
English
Favoritenliste (
0
)
(Voll)
Kontakt
Mein Konto
Abmeldung
Mein Konto
Suche
Filter bei nächster Suche beibehalten
topic_facet:"Phase: Phase 2"
topic_facet:"Syndrome"
NOT title:"systemat review"
Erweiterte Suche
Suchverlauf
Struktursuche
Narrative Service
Drug Overviews
Info Guide
/vufind/Search/Results?filter%5B%5D=topic_facet%3A%22Phase%3A+Phase+2%22&filter%5B%5D=topic_facet%3A%22Syndrome%22&filter%5B%5D=NOT+title%3Asystemat+review&lookfor=%22610%22&type=Subject
/vufind/Search/Results?filter%5B%5D=topic_facet%3A%22Phase%3A+Phase+2%22&filter%5B%5D=topic_facet%3A%22Syndrome%22&filter%5B%5D=NOT+title%3Asystemat+review&lookfor=%22610%22&type=Subject
Search /vufind/Search2/Results?filter%5B%5D=topic_facet%3A%22Phase%3A+Phase+2%22&filter%5B%5D=topic_facet%3A%22Syndrome%22&filter%5B%5D=NOT+title%3Asystemat+review&lookfor=%22610%22&type=Subject
PubPharm (1.450)
1
Fludarabine Phosphate, Cytarabine, Filgrastim-sndz, Gemtuzumab Ozogamicin, and Idarubicin Hydrochloride in Treating Patients With Newly Diagnosed Acute Myeloid Leukemia or High-Risk Myelodysplastic Syndrome : A Phase 2 Study of Fludarabine, Cytarabine, Filgrastim-sndz,Gemtuzumab Ozogamicin and Idarubicin in Newly Diagnosed Core Binding Factor Associated Acute Myelogenous Leukemia
enthalten in:
ClinicalTrials.gov
| 2024
Wird geladen...
2
Evolocumab in Acute Coronary Syndrome : Evolocumab in Acute Coronary Syndrome: A Double-Blind Randomized Placebo Controlled Study
enthalten in:
ClinicalTrials.gov
| 2024
Wird geladen...
3
Study of Safety and Tolerability of CFZ533 in Patients With Sjögren's Syndrome : A TWINSS Extension Trial to Evaluate the Safety and Tolerability of CFZ533 (Iscalimab) at Two Dose Levels Administered Subcutaneously in Patients With Sjögren's Syndrome
enthalten in:
ClinicalTrials.gov
| 2024
Wird geladen...
4
Study of BOTOX Injections to Assess Change in Disease Activity and Adverse Events in Adult Female Participants With Interstitial Cystitis/Bladder Pain Syndrome (IC/BPS) : A Multicenter, Randomized, Double-blind, Placebo-Controlled, Parallel Arm Study to Assess the Safety and Efficacy of a Single Treatment of BOTOX, Followed by an Optional Open-Label Treatment With BOTOX, in Female Subjects With Interstitial Cystitis/Bladder Pain Syndrome (IC/BPS)
enthalten in:
ClinicalTrials.gov
| 2024
Wird geladen...
5
A Study to Evaluate the Safety and Efficacy of Basmisanil Treatment in Children Aged 2-14 Years With Dup15q Syndrome : A Phase II, Randomized, Double-Blind, Placebo-Controlled, Parallel Group Study to Evaluate the Safety, Efficacy, and Pharmacodynamics of 52 Weeks of Treatment With Basmisanil in Participants Aged 2 to 14 Years Old With Dup15q Syndrome Followed by a 2-Year Optional Open-Label Extension
enthalten in:
ClinicalTrials.gov
| 2024
Wird geladen...
6
Efficacy and Safety Study of Efgartigimod in Adults With Post-COVID-19 POTS : A Phase 2 Randomized, Double-blinded, Placebo-controlled Study to Evaluate the Efficacy and Safety of Efgartigimod IV in Adult Patients With Post-COVID-19 Postural Orthostatic Tachycardia Syndrome (POTS)
enthalten in:
ClinicalTrials.gov
| 2024
Wird geladen...
7
Vericiguat in Patients With Metabolic Syndrome and Coronary Vascular Dysfunction : Vericiguat in Patients With Metabolic Syndrome and Coronary Vascular Dysfunction
enthalten in:
ClinicalTrials.gov
| 2024
Wird geladen...
8
Allo HSCT Using RIC and PTCy for Hematological Diseases : Allogeneic Hematopoietic Stem Cell Transplantation Using Reduced Intensity Conditioning (RIC) With Post-Transplant Cytoxan (PTCy) for the Treatment of Hematological Diseases
enthalten in:
ClinicalTrials.gov
| 2024
Wird geladen...
9
Phase II Study of Pacritinib in Kaposi Sarcoma Herpesvirus (KSHV)-Associated Multicentric Castleman Disease and KSHV-Associated Inflammatory Cytokine Syndrome (KICS) : Phase II Study of Pacritinib in Kaposi Sarcoma Herpesvirus (KSHV)-Associated Multicentric Castleman Disease and KSHV-Associated Inflammatory Cytokine Syndrome (KICS)
enthalten in:
ClinicalTrials.gov
| 2024
Wird geladen...
10
Tyrosine Kinase Inhibition to Treat Myeloid Hypereosinophilic Syndrome : Efficacy of Tyrosine Kinase Inhibition in Reducing Eosinophilia in Patients With Myeloid and/or Steroid-Refractory Hypereosinophilic Syndrome
enthalten in:
ClinicalTrials.gov
| 2024
Wird geladen...
1
2
3
4
5
6
7
8
9
10
11
Nächster »
[145]
Filter & Sortierung
Treffer pro Seite
10
20
50
Sortieren
Relevanz
Neueste zuerst
Älteste zuerst
Verfasser
Zeitschriftentitel
Bibliothek
Standort (Printmedien)
Verwandte Substanzen
Verwandte Substanzen werden ermittelt...
Verwandte Erkrankungen/Symptome
Verwandte Erkrankungen/Symptome werden ermittelt...
Verwandte Gene
Verwandte Gene werden ermittelt...
Systematic Reviews
Clinical Studies
Patente
Covid-19/SARS-CoV-2
Filter aufheben
Exclude Systematic Reviews
Exclude Clinical Studies
Exclude Patents
Ihre gewählten Filter
Filter bei nächster Suche beibehalten
Filter aufheben
Alle gewählten Filter entfernen
Filter aufheben
Thema: Phase: Phase 2
Filter aufheben
Thema: Syndrome
Medienart
1.450
Aufsätze
1.450
E-Artikel
1.450
E-Ressourcen
Zeitschriftentitel
1.450
ClinicalTrials.gov
Thema
1.450
610
Phase: Phase 2
1.450
Study Type: Interventional
Syndrome
710
Recruitment Status: Completed
369
Myelodysplastic Syndromes
361
Preleukemia
239
Recruitment Status: Recruiting
203
Leukemia
188
Recruitment Status: Terminated
134
Leukemia, Myeloid
130
Leukemia, Myeloid, Acute
100
Recruitment Status: Active, not recruiting
96
Irritable Bowel Syndrome
71
Recruitment Status: Unknown status
67
Recruitment Status: Withdrawn
66
Respiratory Distress Syndrome, Newborn
62
Leukemia, Myelomonocytic, Chronic
62
Sjogren's Syndrome
61
Leukemia, Myelomonocytic, Juvenile
Alle anzeigen ...
weniger ...
Erscheinungszeitraum
790
2020-
617
2010-2019
43
2000-2009
Erscheinungsjahr(e)
Von:
Bis:
Sprache
1.450
Englisch
Haven't found what you're looking for?
Wird geladen...